Ardelyx Inc (ARDX) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Biotechnology industry.
Over the past 4 years, Ardelyx Inc has achieved a revenue compound annual growth rate (CAGR) of 268.5%, while earnings have grown at -19.7% CAGR.
Historical revenue and profitability trends for Ardelyx Inc
The chart above illustrates Ardelyx Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Ardelyx Inc's business.
How efficiently Ardelyx Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Ardelyx Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Ardelyx Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.6364 based on 11 analysts.
Based on our comprehensive analysis, Ardelyx Inc (ARDX) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Ardelyx Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Ardelyx Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: ARDX Valuation, ARDX Dividend, ARDX Financial Health
Compare: ARDX vs AAPL, ARDX vs MSFT, ARDX vs GOOGL